Events2Join

Severe COVID|19


Severe COVID-19: Symptoms, Risk Factors & Prevention | Pfizer

Severe COVID-19 as an illness is diagnosed based on clinical signs such as respiratory rate and the amount of oxygen in the blood.

Underlying Conditions and the Higher Risk for Severe COVID-19

Background. Age is the strongest risk factor for severe COVID-19 outcomes. Patients with one or multiple certain underlying medical conditions ...

People with Certain Medical Conditions and COVID-19 Risk Factors

Like adults, children and teens with obesity, diabetes, asthma or chronic lung disease, sickle cell disease, or who are immunocompromised can ...

COVID-19: Who's at higher risk of serious symptoms? - Mayo Clinic

Many different diseases can raise the risk of severe COVID-19 illness. Brain and nervous system diseases, such as strokes. Chronic liver disease, specifically ...

Severe Covid-19 | New England Journal of Medicine

Patients with severe coronavirus disease 2019 (Covid-19) may become critically ill with acute respiratory distress syndrome that typically ...

Coronavirus disease 2019 (COVID-19) - Symptoms and causes

COVID-19, also called coronavirus disease 2019, is an illness caused by a virus. The virus is called severe acute respiratory syndrome coronavirus 2, or more ...

Severe COVID-19 and the Continuing Importance of Protecting High ...

Severe outcomes of COVID-19 are defined as hospitalization, admission to the intensive care unit (ICU), intubation or mechanical ventilation, or death.

COVID-19 symptoms and severity - World Health Organization (WHO)

Symptoms of COVID-19 can vary, but mild cases often experience fever, cough, and fatigue. Moderate cases may have difficulty breathing or mild pneumonia. While ...

Features, Evaluation, and Treatment of Coronavirus (COVID-19)

Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Study suggests reinfections from the virus that causes COVID-19 ...

Researchers have found that severe infections from the virus that causes COVID-19 tend to foreshadow similar severity of infection the next time a person ...

Long COVID (Post-COVID Conditions, PCC) - Yale Medicine

The symptoms and conditions, which may last for weeks, months, or years, can be persistent (meaning they developed during an acute COVID-19 illness and haven't ...

COVID-19 signs, symptoms and severity of disease: A clinician guide

Typical symptoms reported during the Omicron wave included runny nose, headache, sneezing, and sore throat.

Remdesivir in adults with severe COVID-19 - The Lancet

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Coronavirus Symptoms: Early Signs, Serious Symptoms - WebMD

But some have severe problems, such as trouble breathing. The odds of more serious COVID-19 symptoms are higher if you're older or have another ...

Recovery From Severe COVID-19: Leveraging the Lessons of ...

Approximately 80% of patients hospitalized with COVID-19, and 60% of those admitted to intensive care units (ICUs), survive. However, similar to ...

Underlying Medical Conditions Associated With Severe COVID-19 ...

This cross-sectional study found a higher risk of severe COVID-19 illness among children with medical complexity and certain underlying conditions.

Genomewide Association Study of Severe Covid-19 with ...

We conducted a genomewide association study involving 1980 patients with Covid-19 and severe disease (defined as respiratory failure) at seven hospitals.

Severe covid-19 pneumonia: pathogenesis and clinical management

This review focuses on the epidemiologic and clinical features of covid-19, the pathophysiologic mechanisms, inpatient respiratory support, and the evidence to ...

What are the symptoms for mild, moderate and severe COVID? - NPR

As for moderate, patients in that category would experience shortness of breath or difficulty breathing. If you're using a device called a pulse ...

COVID-19: Management in hospitalized adults - UpToDate

The disease is designated COVID-19, which stands for coronavirus disease 2019 [1]. The virus that causes COVID-19 is designated severe acute respiratory ...


Symptoms of COVID-19

The symptoms of COVID-19 are variable depending on the type of variant contracted, ranging from mild symptoms to a potentially fatal illness.

COVID-19 vaccine

Vaccine

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019.

Ad26.COV2.S

Vaccine

The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, a subsidiary of American company Johnson & Johnson.

Sinopharm BIBP COVID-19 vaccine

Vaccine https://encrypted-tbn3.gstatic.com/images?q=tbn:ANd9GcRZsMH1hxjXpZWYzvthS6yli7PwuZfUsmQ-7KDPaDZReGKt8jr8

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products.

COVID-19 pandemic in Hong Kong

The COVID-19 pandemic in Hong Kong is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was first confirmed to have spread to Hong Kong on 23 January 2020.

Ad5-nCoV

Vaccine https://encrypted-tbn2.gstatic.com/images?q=tbn:ANd9GcRHz8XkcsrNsc0pcxWMqP87rOjJ5O_DhekajrNL9VZPlXUnSY9d

AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino Biologics, with Phase III trials conducted in Argentina, Chile, Mexico, Pakistan, Russia, and Saudi Arabia with 40,000 participants.